Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9-804-180
Published by: Harvard Business Publishing
Originally published in: 2004
Version: 8 May 2007
Length: 29 pages
Data source: Field research

Abstract

Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief Executive Officer, Frank Litvack, is considering alternative sources of financing to test the device.
Location:
Size:
35 employees
Other setting(s):
2003

About

Abstract

Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief Executive Officer, Frank Litvack, is considering alternative sources of financing to test the device.

Settings

Location:
Size:
35 employees
Other setting(s):
2003

Related